A

Asker Healthcare Group AB
STO:ASKER

Watchlist Manager
Asker Healthcare Group AB
STO:ASKER
Watchlist
Price: 74.7 SEK -1.84% Market Closed
Market Cap: kr28.7B

Wall St Price Targets

ASKER Price Targets Summary
Asker Healthcare Group AB

Wall Street analysts forecast ASKER stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ASKER is 98.94 SEK with a low forecast of 82.82 SEK and a high forecast of 110.25 SEK.

Lowest Forecast
Price Target
82.82 SEK
11% Upside
Average Forecast
Price Target
98.94 SEK
32% Upside
Highest Forecast
Price Target
110.25 SEK
48% Upside
Asker Healthcare Group AB Competitors:
Price Targets
MRNA
Moderna Inc
-65% Downside
NEPHROPLUS
Nephrocare Health Services Ltd
16% Upside
1INN
innoscripta SE
189% Upside
ROKU
Roku Inc
-2% Downside

Revenue
Forecast

12% / Year
Past Growth
-6% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
12% / Year
Past Growth
-6% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 2 years, the compound annual growth rate for Revenue has been 12%. The projected CAGR for the next 5 years is -6%.

Gross Profit
Forecast

23% / Year
Past Growth
9% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
23% / Year
Past Growth
9% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 2 years, the compound annual growth rate for Gross Profit has been 23%. The projected CAGR for the next 5 years is 9%.

Operating Income
Forecast

31% / Year
Past Growth
5% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
31% / Year
Past Growth
5% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 2 years, the compound annual growth rate for Operating Income has been 31%. The projected CAGR for the next 4 years is 5%.

Pre-Tax Income
Forecast

46% / Year
Past Growth
12% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
46% / Year
Past Growth
12% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 2 years, the compound annual growth rate for Pre-Tax Income has been 46%. The projected CAGR for the next 3 years is 12%.

Net Income
Forecast

51% / Year
Past Growth
22% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
51% / Year
Past Growth
22% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 2 years, the compound annual growth rate for Net Income has been 51%. The projected CAGR for the next 4 years is 22%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is ASKER's stock price target?
Price Target
98.94 SEK

According to Wall Street analysts, the average 1-year price target for ASKER is 98.94 SEK with a low forecast of 82.82 SEK and a high forecast of 110.25 SEK.

What is the Revenue forecast for Asker Healthcare Group AB?
Projected CAGR
-6%

Over the last 2 years, the compound annual growth rate for Revenue has been 12%. The projected CAGR for the next 5 years is -6%.

What is the Gross Profit forecast for Asker Healthcare Group AB?
Projected CAGR
9%

Over the last 2 years, the compound annual growth rate for Gross Profit has been 23%. The projected CAGR for the next 5 years is 9%.

What is the Operating Income forecast for Asker Healthcare Group AB?
Projected CAGR
5%

Over the last 2 years, the compound annual growth rate for Operating Income has been 31%. The projected CAGR for the next 4 years is 5%.

What is the Pre-Tax Income forecast for Asker Healthcare Group AB?
Projected CAGR
12%

Over the last 2 years, the compound annual growth rate for Pre-Tax Income has been 46%. The projected CAGR for the next 3 years is 12%.

What is the Net Income forecast for Asker Healthcare Group AB?
Projected CAGR
22%

Over the last 2 years, the compound annual growth rate for Net Income has been 51%. The projected CAGR for the next 4 years is 22%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett